Graft versus host disease Trials in Hackensack, United States
Conditions / Graft versus host disease / Hackensack, United States
Graft versus host disease is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00003056 | Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation | TERMINATED | PHASE3 |
| NCT00003661 | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | COMPLETED | PHASE2 |
| NCT01002742 | Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) | COMPLETED | PHASE3 |
| NCT05263999 | A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) | TERMINATED | PHASE3 |
| NCT00366145 | Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE3 |
| NCT00382109 | Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission | COMPLETED | PHASE3 |
| NCT00003662 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | COMPLETED | PHASE2 |
| NCT00759018 | Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD | NO_LONGER_AVAILABLE | — |
| NCT00031824 | Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease | COMPLETED | PHASE3 |
| NCT00489203 | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | COMPLETED | PHASE2 |